| Stage | AMGN | % of rev | PLX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $10.4B | 100.00% | $20M | 100.00% | AMGN ×520.96 |
| Gross profit | $7.6B | 73.10% | $12M | 60.99% | AMGN +12.1pp |
| Operating income | $3.7B | 35.79% | $5M | 23.48% | AMGN +12.3pp |
| Pre-tax income | $4.7B | 45.21% | $5M | 24.43% | AMGN +20.8pp |
| Net income | $3.9B | 37.28% | $4M | 18.98% | AMGN +18.3pp |
| Stage | AMGN | PLX | Gap · A − B |
|---|---|---|---|
| Revenue | $10.4B100.00% | $20M100.00% | AMGN ×520.96 |
| Gross profit | 73.10%$7.6B | 60.99%$12M | AMGN +12.1pp |
| Operating income | 35.79%$3.7B | 23.48%$5M | AMGN +12.3pp |
| Pre-tax income | 45.21%$4.7B | 24.43%$5M | AMGN +20.8pp |
| Net income |
| 37.28%$3.9B |
| 18.98%$4M |
| AMGN +18.3pp |
No shared counterparties.